✦ LIBER ✦

Localization of plasminogen activator(s) in primary and secondary rat adenocarcinoma cells

✍ Scribed by R. Ng; Aileen Wong; J. A. Kellen

Publisher: Springer
Year: 1985
Tongue: English
Weight: 67 KB
Volume: 3
Category: Article
ISSN: 0262-0898
DOI: 10.1007/bf01758955

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of tissue plasminogen activat

Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes

✍ Kyoung Ja Kwon; Kyu Suk Cho; Sung Hoon Lee; Jung Nam Kim; So Hyun Joo; Jong Hoon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 863 KB

## Abstract Although originally known as a plasma serine protease involved in clot dissolution, tPA and its primary inhibitor, PAI‐1, play crucial roles in synaptic reorganization and plasticity in the central nervous system. In contrast to the wide array of work conducted in neural cells, relative

Characterization of the rat urokinase pl

Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells

✍ Feng Su; Katherine R. Kozak; Harvey Herschman; Srinivasa T. Reddy; Robin Farias- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 1 views

## Abstract Rat PC12 pheochromocytoma cells treated with nerve growth factor (NGF) extend “neurites” and initiate a neuronal differentiation pathway. Although neurotrophins, growth factors [e.g., epidermal growth factor (EGF)], and other ligands induce many common primary response genes (PRGs) in P

Immunohistochemical localization of the

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

✍ Elisabetta Bianchi; Robert L. Cohen; Aihua Dai; Ann T. Thor; Marc A. Shuman; Hel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 848 KB

We used an immunohistochemical assay with an antigenretrieval technique to study plasminogen activator inhibitor type-I (PAL I) expression in paraffin-embedded breast tissue samples at different stages of malignant transformation. We detected PAI-I in 15/20 invasive tumors. In several cases staining

Enhanced release of plasminogen activato

Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1

✍ B. Rogister; P. Leprince; P. Delree; J. Van Damme; A. Billiau; G. Moonen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

## Abstract Astroglial cells are known to proliferate during development of the nervous system, as well as during post‐traumatic gliosis. We have previously shown that the proliferation of cultured astrocytes can be stimulated by the urokinase‐type (uPA) of plasminogen activator (PA) and that astro

Comparative evaluation of urokinase-type

Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells

✍ Alice Hemsen; Lutz Riethdorf; Nils Brünner; Jürgen Berger; Sebastian Ebel; Chris 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB 👁 1 views

## Abstract The urokinase‐type plasminogen activator receptor (uPAR, CD87) plays a central role in the plasminogen activation cascade, which participates in extracellular matrix degradation, cell migration and invasion. Here we performed a comprehensive immmunohistochemical evaluation of uPAR expre

Plasminogen activator inhibitor 1, the p

Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid

✍ Jasti S. Rao; M. Chen; Barry W. Festoff 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

The occurrence of type-1 plasminogen activator inhibitor (PAI-1) in human cerebrospinal fluid (CSF) has not previously been reported. As a member of the serpin superfamily of serine protease inhibitors and an acute phase response component, PAI-1 has powerful potential roles in nervous system homeos